Clinical Trial Update: A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability, and exploratory efficacy of EHT 0202 as an adjunct to acetylcholinesterase inhibitors in mild-to-moderate Alz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• EHT 0202

Snippet

Sponsor: Exonhit | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED